GILD · Healthcare
Gilead Sciences Inc
33/100
Smart-money confidence1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
44
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$171.3B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About GILEAD SCIENCES INC
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a…
Who's behind the signal
Every informed buyer we can see on GILD, across all three feeds.
Hedge funds · 8
Tudor Investment (Paul Tudor Jones)
New position
Point72 (Steve Cohen)
New position
Citadel Advisors
Increased +2%
Gotham Asset Mgmt (Greenblatt)
Increased +26%
Millennium Management (Englander)
Increased +769%
D.E. Shaw & Co
Increased +4%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 48 on record
Disclosures from 2014-04-14 to 2024-05-10
The newest disclosure we hold for this stock is 2024-05-10.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2024-05-10 | Tommy Tuberville · R-AL | Senate | Bought | $1,001 - $15,000 |
| 2022-09-09 | Zoe Lofgren · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-11-10 | Carol D. Miller · R-WV | House | Sold | $15,001 - $50,000 |
| 2021-09-01 | Zoe Lofgren · D-CA | House | Sold | $1,001 - $15,000 |
| 2021-04-09 | Sara Jacobs · D-CA | House | Sold | $15,001 - $50,000 |
| 2021-02-11 | Ro Khanna · D-CA | House | Bought | $1,001 - $15,000 |
| 2021-01-21 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2020-12-22 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2020-12-18 | Dean Phillips · D-MN | House | Sold | $1,001 - $15,000 |
| 2020-09-23 | Dean Phillips · D-MN | House | Bought | $1,001 - $15,000 |
Show the other 38
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2020-09-01 | Ed Perlmutter · D-CO | House | Sold | $1,001 - $15,000 |
| 2020-08-21 | Jerry Moran · R-KS | Senate | Bought | $1,001 - $15,000 |
| 2020-07-15 | Ed Perlmutter · D-CO | House | Bought | $1,001 - $15,000 |
| 2020-07-08 | Roger Marshall · R-KS | House | Sold | $1,001 - $15,000 |
| 2020-06-29 | William R. Timmons IV · R-SC | House | Sold | $1,001 - $15,000 |
| 2020-05-07 | Roger Marshall · R-KS | House | Bought | $1,001 - $15,000 |
| 2020-05-05 | Roger Marshall · R-KS | House | Bought | $1,001 - $15,000 |
| 2020-05-04 | Roger Marshall · R-KS | House | Bought | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2020-02-07 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-01-21 | Mikie Sherrill · D-NJ | House | Bought | $1,001 - $15,000 |
| 2019-12-18 | Mikie Sherrill · D-NJ | House | Sold | $1,001 - $15,000 |
| 2019-09-25 | Jerry Moran · R-KS | Senate | Bought | $1,001 - $15,000 |
| 2019-03-11 | Shelley Moore Capito · R-WV | Senate | Sold | $1,001 - $15,000 |
| 2018-09-25 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2018-04-23 | Angus S. King, Jr. · I-ME | Senate | Sold | $1,001 - $15,000 |
| 2018-02-22 | James M. Inhofe · R-OK | Senate | Sold | $50,001 - $100,000 |
| 2017-10-25 | Shelley Moore Capito · R-WV | Senate | Bought | $1,001 - $15,000 |
| 2017-09-20 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2017-09-20 | Sheldon Whitehouse · D-RI | Senate | Sold | $15,001 - $50,000 |
| 2017-06-15 | Patty Murray · D-WA | Senate | Sold | $1,001 - $15,000 |
| 2017-03-16 | Patty Murray · D-WA | Senate | Bought | $1,001 - $15,000 |
| 2017-03-02 | Susan M. Collins · R-ME | Senate | Sold | $1,001 - $15,000 |
| 2016-12-23 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-12-15 | James M. Inhofe · R-OK | Senate | Bought | $50,001 - $100,000 |
| 2016-11-28 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-11-15 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-09-06 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-07-21 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-05-18 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2016-01-28 | James M. Inhofe · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2016-01-05 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-06-09 | James M. Inhofe · R-OK | Senate | Sold | $50,001 - $100,000 |
| 2015-04-07 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-01-23 | Sheldon Whitehouse · D-RI | Senate | Bought | $15,001 - $50,000 |
| 2014-11-10 | Susan M. Collins · R-ME | Senate | Bought | $1,001 - $15,000 |
| 2014-04-14 | Susan M. Collins · R-ME | Senate | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
GILEAD SCIENCES INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
2
New positions
4
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.0%
Position change
NEW
0.0% of Tudor Investment's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.4%
Position change
+2%
0.4% of Citadel Advisors's portfolio
Trust weight: 1.1×
% of portfolio
0.2%
Position change
+26%
0.2% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+769%
0.1% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+4%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
−38%
0.1% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−57%
0.1% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to GILEAD SCIENCES INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell GILEAD SCIENCES INC or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime